3 Top Generic Drug Stocks to Consider Buying Now
Brand-name drugs tend to capture all the headlines, but did you know that nine out of every 10 prescriptions filled in the U.S. each year are generic? When added together, Americans spend spent about $116 billion on generic drugs in 2016, according to Statista. The numbers get much larger when you zoom to include the rest of the world.
Given the size of the market, it should come as no surprise to see that scores of pharma companies want a piece of the action. Here's a list of 10 publicly traded companies that are major competitors in the generic drug space.
Table Source: Yahoo! Finance
Source: Fool.com
Pfizer Inc. Aktie
26,00 €
1,31 %
Die Pfizer Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 41 € für Pfizer Inc. weist auf eine Steigerung von über 50% gegenüber dem aktuellen Kurs von 26.0 € hin.
